Corey N. Fishman
Net Worth

Last updated:

What is Corey N. Fishman net worth?

The estimated net worth of Mr. Corey N. Fishman is at least $7,536,826 as of 20 Nov 2023. He owns shares worth $46,826 as insider and has received compensation worth at least $7,490,000 in Iterum Therapeutics plc.

What is the salary of Corey N. Fishman?

Mr. Corey N. Fishman salary is $1,070,000 per year as Pres, Chief Executive Officer & Director in Iterum Therapeutics plc.

How old is Corey N. Fishman?

Mr. Corey N. Fishman is 60 years old, born in 1965.

What stocks does Corey N. Fishman currently own?

As insider, Mr. Corey N. Fishman owns shares in one company:

Company Title Shares Price per share Total value
Iterum Therapeutics plc (ITRM) Pres, Chief Executive Officer & Director 54,449 $0.86 $46,826

What does Iterum Therapeutics plc do?

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Corey N. Fishman insider trading

Iterum Therapeutics plc

Mr. Corey N. Fishman has made only one insider trade between 2018-2023, according to the Form 4 filled with the SEC. He purchased 10,000 units of ITRM stock worth $15,860 on 20 Nov 2023.

As of 20 Nov 2023 he still owns at least 54,449 units of ITRM stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Ordinary Shares 10,000 $1.59 $15,860
Option
Restricted Share Units 14,333 N/A N/A
Option
Restricted Share Units 215,000 N/A N/A
Option
Ordinary Shares 215,000 N/A N/A
Sale
Ordinary Shares 85,445 N/A N/A
Purchase
Ordinary Shares 2,000 $8.73 $17,466
Purchase
Ordinary Shares 3,000 $13 $39,000

Iterum Therapeutics key executives

Iterum Therapeutics plc executives and other stock owners filed with the SEC: